| 1 |
唐神结，高文. 临床结核病学[M]. 2版. 北京：人民卫生出版社，2019：1026-1046.
|
| 2 |
Furuuchi K, Morimoto K, Yoshiyama T, et al. Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan[J]. Respir Med, 2019,152:74-80.
|
| 3 |
Prevots DR, Marras TK. Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review[J]. Clin Chest Med, 2015,36(1):13-34.
|
| 4 |
Daley CL, Iaccarino JM, Lange C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline[J]. Eur Respir J, 2020,56(1):2000535.
|
| 5 |
Haworth CS, Banks J, Capstick T, et al. British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)[J]. Thorax, 2017,72(Suppl.2): ii1-ii64.
|
| 6 |
中华医学会结核病学分会，《中华结核和呼吸杂志》编辑委员会. 非结核分枝杆菌病诊断与治疗专家共识[J]. 中华结核和呼吸杂志，2012,35(8):572-580.
|
| 7 |
中华医学会器官移植学分会. 器官移植受者非结核分枝杆菌病临床诊疗技术规范(2019版)[J]. 器官移植，2019,10(4):364-368.
|
| 8 |
van Ingen J．Diagnosis of nontuberculous mycobacterial infections[J]. Semin Respir Crit Care Med, 2013,34(1):103-109.
|
| 9 |
George IA, Santos CA, Olsen MA, et al. Epidemiology and outcomes of nontuberculous mycobacterial infections in solid organ transplant recipients at a midwestern center[J]. Transplantation, 2016,100(5):1073-1078.
|
| 10 |
Smith GS, Ghio AJ, Stout JE, et al. Epidemiology of nontuberculous mycobacteria isolations among central North Carolina residents, 2006-2010[J]. J Infect, 2016,72(6):678-686.
|
| 11 |
Adjemian J, Daniel-Wayman S, Ricotta E, et al. Epidemiology of nontuberculous mycobacteriosis[J]. Semin Respir Crit Care Med, 2018,39(3):325-335.
|
| 12 |
Johansen MD, Herrmann JL, Kremer L. Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus[J]. Nat Rev Microbiol, 2020,18(7):392-407.
|
| 13 |
Winthrop KL, Marras TK, Adjemian J, et al. Incidence and prevalence of nontuberculous mycobacterial lung disease in a large U．S. managed care health plan, 2008-2015[J]. Ann Am Thorac Soc, 2020,17(2):178-185.
|
| 14 |
Wu J, Zhang Y, Li J, et al. Increase in nontuberculous mycobacteria isolated in Shanghai, China: results from a population-based study[J]. PLoS One, 2014, 9(10): e109736.
|
| 15 |
张洁，苏建荣，丁北川，等. 北京地区非结核分枝杆菌菌种分布及耐药性研究[J]. 中华结核和呼吸杂志，2017,40(3):210-214.
|
| 16 |
Baliga S, Murphy C, Sharon L, et al. Rapid method for detecting and differentiating Mycobacterium tuberculosis complex and non-tuberculous mycobacteria in sputum by fluorescence in situ hybridization with DNA probes[J]. Int J Infect Dis, 2018,75:1-7.
|
| 17 |
KunduracıH. Identification of mycobacteria species by molecular methods[J]. Int Wound J, 2020,17(2):245-250.
|
| 18 |
Ju CR, Lian QY, Guan WJ, et al. Metagenomic next-generation sequencing for diagnosing infections in lung transplant recipients: a retrospective study[J]. Transpl Int, 2022,35(2):10265.
|
| 19 |
Lian QY, Chen A, Zhang JH, et al. High-throughput next-generation sequencing for identifying pathogens during early-stage post-lung transplantation[J]. BMC Pulm Med, 2021,21(1):348.
|
| 20 |
Zhou X, Wu H, Ruan Q, et al. Clinical evaluation of diagnosis efficacy of active Mycobacterium tuberculosis complex infection via metagenomic next-generation sequencing of direct clinical samples[J]. Front Cell Infect Microbiol, 2019,9:351.
|
| 21 |
Shah SK, McAnally KJ, Seoane L, et al. Analysis of pulmonary non-tuberculous mycobacterial infections after lung transplantation[J]. Transpl Infect Dis, 2016,18(4):585-591.
|
| 22 |
Choi Y, Lee KS, Kim SK, et al. Unilateral lung involvement of nodular bronchiectatic Mycobacterium avium complex pulmonary diseases: proportion and evolution on serial CT studies[J]. AJR Am J Roentgenol, 2019,212(5):1010-1017.
|
| 23 |
Kwak N, Lee CH, Lee HJ, et al. Non-tuberculous mycobacterial lung disease: diagnosis based on computed tomography of the chest[J]. Eur Radiol, 2016,26(12):4449-4456.
|
| 24 |
Renoult E, Fortin C, Dorais J, et al. Mycobacterium genavense and chronic intermittent diarrhea in a kidney and pancreas transplant recipient[J]. Transplantation, 2013,96(8):e64-e66.
|
| 25 |
Desikan P, Trivedi SK, Atlani MK. Pericardial effusion caused by Mycobacterium chelonae after renal transplant[J]. Arab J Nephrol Transplant, 2013,6(1):55.
|
| 26 |
Ishii K, Ishii N, Nakanaga K, et al. Mycobacterium haemophilum infection with prominent facial manifestation mimicking leprosy[J]. J Dermatol, 2015,42(10):992-995.
|
| 27 |
Copeland NK, Arora NS, Ferguson TM. Mycobacterium haemophilum masquerading as leprosy in a renal transplant patient[J]. Case Rep Dermatol Med, 2013:793127.
|
| 28 |
Philley JV, Griffith DE. Medical management of pulmonary nontuberculous mycobacterial disease[J]. Thorac Surg Clin, 2019,29(1):65-76.
|
| 29 |
Richard M, Gutiérrez AV, Kremer L. Dissecting erm(41)-mediated macrolide-inducible resistance in Mycobacterium abscessus[J]. Antimicrob Agents Chemother, 2020,64(2): e01879-19.
|
| 30 |
Carvalho NFG, Pavan F, Sato DN, et al. Genetic correlates of clarithromycin susceptibility among isolates of the Mycobacterium abscessus group and the potential clinical applicability of a PCR-based analysis of erm(41)[J]. J Antimicrob Chemother, 2018,73(4):862-866.
|
| 31 |
Zhang Z, Lu J, Du Y, et al. Comparison of in vitro synergistic effect between clarithromycin or azithromycin in combination with amikacin against Mycobacterium intracellulare[J]. J Glob Antimicrob Resist, 2019,18:183-186.
|
| 32 |
Yoo JW, Jo KW, Kim SH, et al. Incidence, characteristics, and treatment outcomes of mycobacterial diseases in transplant recipients[J]. Transpl Int, 2016,29(5):549-558.
|
| 33 |
Jankovic Makek M, Pavlisa G, Jakopovic M, et al. Early onset of nontuberculous mycobacterial pulmonary disease contributes to the lethal outcome in lung transplant recipients: report of two cases and review of the literature[J]. Transpl Infect Dis, 2016,18(1):112-119.
|
| 34 |
Swenson C, Del Parigi A. Amikacin liposome inhalation suspension as a treatment option for refractory nontuberculous mycobacterial lung disease caused by mycobacterium avium complex[J]. Mayo Clin Proc, 2020,95(1):201-202.
|
| 35 |
Choi Y, Jhun BW, Kim J, et al. Clinical characteristics and outcomes of surgically resected solitary pulmonary nodules due to nontuberculous mycobacterial infections[J]. J Clin Med, 2019,8(11): 1898.
|
| 36 |
Yamada K, Seki Y, Nakagawa T, et al. Outcomes and risk factors after adjuvant surgical treatments for Mycobacterium avium complex lung disease[J]. Gen Thorac Cardiovasc Surg, 2019,67(4):363-369.
|